Genomic Medicine Program Advisory Committee; Notice of Meeting, 27636 [07-2397]

Download as PDF 27636 Federal Register / Vol. 72, No. 94 / Wednesday, May 16, 2007 / Notices that a meeting of the Clinical Science Research and Development Service Cooperative Studies Scientific Merit Review Board will be held on June 13, 2007, in the Capitol Room 5th Floor at the International Square Center, 1875 I Street NW., Washington, DC. The meeting is scheduled to begin at 8:30 a.m. and end at 4 p.m. The Board advises the Chief Research and Development Officer through the Director of the Clinical Science Research and Development Service on the relevance and feasibility of proposed studies, the adequacy of the protocols and the scientific validity and propriety of technical details, including protection of human subjects. The session will be open to the public from 8:30 a.m. to 9 a.m. for the discussion of administrative matters and the general status of the program. The session will be closed from 9 a.m. to 4 p.m. for the Board’s review of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents, and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). Those who plan to attend should contact Dr. Grant Huang, Deputy Director, Cooperative Studies Program (125), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420 at (202) 254– 0183. Dated: May 9, 2007. By direction of the Secretary. E. Philip Riggin, Committee Management Officer. [FR Doc. 07–2395 Filed 5–15–07; 8:45 am] BILLING CODE 8320–01–M DEPARTMENT OF VETERANS AFFAIRS cprice-sewell on PROD1PC66 with NOTICES Genomic Medicine Program Advisory Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that the Genomic Medicine Program Advisory Committee will meet on June 11, 2007 in the Virginia Room, 2nd floor, at the Mayflower Renaissance Hotel, 1127 Connecticut Avenue, NW., VerDate Aug<31>2005 15:27 May 15, 2007 Jkt 211001 Washington, DC. The meeting will convene at 8 a.m. and adjourn at 5:30 p.m. The meeting is open to the public. The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care of veterans and to enhance development of tests and treatments for diseases particularly relevant to veterans. At the June 11 meeting, the Committee will receive an overview of the VA health care system and electronic medical record, and will be asked to provide insight into optimal ways for VA to incorporate genomic information into its health care program while applying appropriate ethical oversight and protecting the privacy of veterans. Members of the public may make oral statements, limited to 5 minutes each, during the period reserved for public comments. They may also submit, at the time of the meeting, a 1–2 page summary of each statement for inclusion in the official meeting record. Any member of the public seeking additional information should contact Dr. Timothy O’Leary at timothy.oleary@va.gov. Dated: May 9, 2007. By direction of the Secretary. E. Philip Riggin, Committee Management Officer. [FR Doc. 07–2397 Filed 5–15–07; 8:45 am] BILLING CODE 8320–01–M DEPARTMENT OF VETERANS AFFAIRS Advisory Committee on Women Veterans; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that the Advisory Committee on Women Veterans will conduct a site visit on June 4–8, 2007, to the VA Palo Alto Health Care System (VAPAHCS), 3801 Miranda Avenue, Palo Alto, CA. Unless otherwise indicated, all briefings and updates will be held at the VA Palo Alto Health Care System. Site visit briefings, updates, and tours will be held from 8:30 a.m. until 4:30 p.m. each day and will be open to the public. The purpose of the Committee is to advise the Secretary of Veterans Affairs, regarding the needs of women veterans with respect to health care, rehabilitation, compensation, outreach, and other programs and activities administered by VA designed to meet such needs. The Committee will make PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 recommendations to the Secretary regarding such programs and activities. On June 4, the agenda topics for this meeting will include briefings and updates from key leadership of the VAPAHCS and Polytrauma Center, as well as a tour of the polytrauma area, Medical Surgical Intensive Care Unit (MSICU), laboratory, hospice, and pharmacy. On June 5, the Committee will receive briefings and updates on the VAPAHCS Women’s Health Center, resident training, academic affairs/ research, quality assurance, and surgical services. On June 6, the Committee will receive briefings from key leadership of the Veterans Integrated Service Network 21 (Sierra Pacific Network), California State Department of Veterans Affairs, Oakland VA Regional Office, VA National Cemetery Service, Redwood City Vet Center, and VAPAHCS’s communitybased outpatient clinics (CBOSs). On June 7, the Committee will visit the Menlo Park Division of the VAPAHCS, located at 795 Willow Road, Menlo Park, CA. The Committee will receive briefings and updates on the Women’s Mental Health Program, inpatient Post-Traumatic Stress Disorder (PTSD), program, drug addiction programs, crisis intervention, OIF Help Center, chaplain services for women veterans, and the Health Resources Initiatives for Veterans Everywhere (THRIVE). The Committee will tour the resource center for women veterans, the domiciliary, and the substance abuse inpatient unit. On June 8, the Committee will receive briefings and updates on veteran service organizations, nursing services, and inpatient acute psychiatry building plans for privacy issues. These presentations will be followed by an open forum and town hall meeting. The five day site visit will conclude with an exit briefing by VAPAHCS leadership. Any member of the public wishing to attend or seeking additional information should contact Ms. Chanel BankstonCarter at the Department of Veterans Affairs, Center for Women Veterans (00W), 810 Vermont Avenue, NW., Washington, DC 20420. Ms. BankstonCarter may be contacted either by phone at (202) 273–6193, fax at (202) 273– 7092, or e-mail at 00W@mail.va.gov. Interested persons may attend, appear before, or file statements with the Committee. Written statements must be filed before the meeting or within 10 days after the meeting. Dated: May 9, 2007. E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 72, Number 94 (Wednesday, May 16, 2007)]
[Notices]
[Page 27636]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2397]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that the Genomic Medicine 
Program Advisory Committee will meet on June 11, 2007 in the Virginia 
Room, 2nd floor, at the Mayflower Renaissance Hotel, 1127 Connecticut 
Avenue, NW., Washington, DC. The meeting will convene at 8 a.m. and 
adjourn at 5:30 p.m. The meeting is open to the public.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care of veterans and to enhance 
development of tests and treatments for diseases particularly relevant 
to veterans.
    At the June 11 meeting, the Committee will receive an overview of 
the VA health care system and electronic medical record, and will be 
asked to provide insight into optimal ways for VA to incorporate 
genomic information into its health care program while applying 
appropriate ethical oversight and protecting the privacy of veterans.
    Members of the public may make oral statements, limited to 5 
minutes each, during the period reserved for public comments. They may 
also submit, at the time of the meeting, a 1-2 page summary of each 
statement for inclusion in the official meeting record. Any member of 
the public seeking additional information should contact Dr. Timothy 
O'Leary at timothy.oleary@va.gov.

    Dated: May 9, 2007.
    By direction of the Secretary.

E. Philip Riggin,
Committee Management Officer.
[FR Doc. 07-2397 Filed 5-15-07; 8:45 am]
BILLING CODE 8320-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.